SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-128949
Filing Date
2021-10-22
Accepted
2021-10-22 16:01:14
Documents
12
Period of Report
2021-05-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2130863d1_8ka.htm   iXBRL 8-K/A 30237
  Complete submission text file 0001104659-21-128949.txt   204045

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA icpt-20210527.xsd EX-101.SCH 3210
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20210527_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20210527_pre.xml EX-101.PRE 22727
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2130863d1_8ka_htm.xml XML 3697
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35668 | Film No.: 211340530
SIC: 2834 Pharmaceutical Preparations